Monoclonal Antibodies: Technology Maturation and New Strategies

Monoclonal Antibodies: Technology Maturation and New Strategies is organized by Society for Translational Oncology (STO).

Released: 5/18/2021 
Expires: 5/19/2022 

Target Audience:
Physicians who wish to advance their current knowledge of Monoclonal Antibodies.

Learning Objectives:
• Define mechanisms of action of antibody-based antitumor therapy
• Summarize therapeutic properties of, pharmacology of, and mechanisms of resistance to monoclonal antibody cancer treatment
• Describe links between antibody- and cell-based therapies